Cybin is listed on the NASDAQ stock exchange, receiving buy rating coverage from TD Cowen, while Millennium Management increased its stake.
8 reports, 1 independent
Updated Oct 22
Gone quiet
- Reports
- 8
- Developments
- 1
- Repetition
- 88%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cybin is listed on the NASDAQ stock exchange, receiving buy rating coverage from TD Cowen, while Millennium Management increased its stake.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cybin
Canadian pharmaceutical company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
TD Cowen
American investment bank
Related events
- TD Cowen, Bank of America, and Royal Bank of Canada issued new ratings and coverage notes on November 5, 2026.
- TD Cowen boosted its price target and gave a buy rating for Jazz Pharmaceuticals.
- Analyst firms Jefferies, TD Cowen, and Raymond James Financial provided rating updates for Black Diamond Therapeutics, alongside MarketBeat consensus data.
- Multiple financial firms, including TD Cowen, Goldman Sachs, and Mizuho, issued various rating changes and price target updates across several stocks.
- TD Cowen increased its price objective on BP shares, and HSBC raised BP's rating and target price.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- dailypolitical.comWells Fargo & Company Begins Coverage on Cybin (NASDAQ:HELP)
- dailypolitical.com